IDEAYA Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for IDYA, updated each market day.
IDYA AI Sentiment
AI sees no strong directional signal for IDEAYA Biosciences, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Sector
Exchange
Market Cap
$2,722,234,837
Cap Tier
Employees
145
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
May 23, 2019
Website
IDYA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IDYA Volatility
IDEAYA Biosciences, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
